The weekly litigation news digest is live. Subscribe now

IP Verse

Beta-2 Microglobulin-Deficient Cells - EP2699593

The patent EP2699593 was granted to University OF Washington Through ITS Center FOR Commercialization on Nov 4, 2020. The application was filed on Apr 18, 2012 under application number EP12720040A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2699593

UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Application Number
EP12720040A
Filing Date
Apr 18, 2012
Status
Patent Maintained As Amended
Oct 2, 2020
Publication Date
Nov 4, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JAMES POOLEMay 30, 2018MARSHALL -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2008219956
DESCRIPTIONUS4892538
DESCRIPTIONUS5011472
DESCRIPTIONUS5837234
DESCRIPTIONWO9110425
DESCRIPTIONWO9110470
INTERNATIONAL-SEARCH-REPORTUS6514752
INTERNATIONAL-SEARCH-REPORTWO9209688
OPPOSITIONUS2005196404
OPPOSITIONUS6514752
OPPOSITIONWO9209688

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents